DIAG-NOSE MEDICAL
Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments. The company is working on an affordable, rapid, and non-invasive self-test to determine the right treatment pathway for patients with acute sinusitis and to promote antibiotic stewardship for clinicians. Diag-Nose Medical flagship product, the “RHINOSENSE” is a point-of-care test that combines non-invasive nasal sampling, lateral flow immunoassays, and host-immune markers to differentiate between viral, bacterial, and allergy mediated sinusitis.
DIAG-NOSE MEDICAL
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2020-02-13
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.diag-nose.com.au
Total Employee:
1+
Status:
Active
Total Funding:
525 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail ReCAPTCHA Microsoft Azure DNS
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
More informations about "Diag-Nose Medical"
Diag-Nose Medical
[email protected]. Address Australia: 660 Lorimer street, Port Melbourne, VIC 3207. United States: 3445 HIGH POINT BLVD, BETHLEHEM, PA 18017 ©Diag-Nose Medical 2025. Follow …See details»
Diag-Nose.io - Crunchbase Company Profile & Funding
Diag-Nose.io, founded in 2020 is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug …See details»
Diag-Nose.io - LinkedIn
Diag-Nose.io, founded in 2020 and headquartered in Melbourne, Australia, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic …See details»
Investment Update: Diag-nose.io - Breakthrough Victoria
Jan 29, 2025 WHAT IS DIAG-NOSE.io? Diag-Nose Medical (DNM) is a Melbourne-based company focused on enhancing research into drug treatments for chronic respiratory diseases …See details»
Diag-Nose.io raises $3.2m — Capital Brief
Jan 29, 2025 The news: Melbourne-based biotechnology company Diag-Nose.io Medical (DNM) has raised $3.15 million to advance its respiratory disease …See details»
DIAG-NOSE MEDICAL PTY LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DIAG-NOSE MEDICAL PTY LTD of PORT MELBOURNE, VICTORIA. Get the latest business insights from …See details»
Diag-Nose.io - Breakthrough Victoria
Jan 29, 2025 Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based company improving clinical management and drug discovery for chronic …See details»
Diag-Nose.io 2025 Company Profile: Valuation, …
Jun 28, 2023 Diag-Nose.io General Information Description. Operator of a precision medicine platform intended to improve the diagnosis and treatment of chronic nasal disorders. The company combines protein biomarkers, digital …See details»
Diag-Nose.io Announced As Australia's First Health Tech Start-up …
MELBOURNE, Victoria, 6th July 2023 - Diag-Nose.io, a pioneering Australian health tech start-up has emerged triumphant from four intense elimination rounds in the highly competitive …See details»
About us – Diag-Nose Medical
[email protected]. Address Australia: 660 Lorimer street, Port Melbourne, VIC 3207. United States: 3445 HIGH POINT BLVD, BETHLEHEM, PA 18017 ©Diag-Nose Medical 2025. Follow us. Contact us. Let’s Talk.See details»
Diag-Nose Biotechtronics - VentureRadar
Diag-Nose Biotechtronics is a Joint Venture between BWT Group (UK) and E-Nose (Australia). E-Nose develops electronic nose devices for use in Medical, Veterinary, Air Pollution, Security …See details»
Breakthrough Victoria invests $800,000 in Melbourne's Diag …
Jan 30, 2025 Breakthrough Victoria has invested $800,000 in Diag-Nose.io Medical (DNM), a Melbourne-based innovator in respiratory healthcare, to enhance clinical management and …See details»
Investing In Medtech So Patients Can Breathe Easier | Premier
Jan 30, 2025 The Allan Labor Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic respiratory disorders, which has the …See details»
Diag-Nose.io - LinkedIn
Diag-Nose.io | 615 followers on LinkedIn. Mapping the unified airway to discover lifesaving medicines and deliver breakthrough respiratory care. | Diag-Nose.io, founded in 2020 and …See details»
Biotech Diag-Nose.io Medical raises $3.15m in seed round
Jan 30, 2025 Breakthrough Victoria says Diag-Nose.io Medical is initially focusing on research applications, which can help generate valuable data for future clinical applications. The …See details»
PERTH HEALTHTECH STARTUP DIAG-NOSE ACCEPTED INTO …
Perth Biodesign graduate and Course Co-Director of Perth Biodesign for Digital Health, Eldin Rostom, has been accepted into the 2020 cohort of the MedTech Actuator with his HealthTech …See details»
Technology – Diag-Nose Medical
[email protected]. Address Australia: 660 Lorimer street, Port Melbourne, VIC 3207. United States: 3445 HIGH POINT BLVD, BETHLEHEM, PA 18017 ©Diag-Nose Medical 2025. Follow …See details»
DIAG-NOSE.IO ANNOUNCED AS AUSTRALIA’S FIRST HEALTHTECH …
MELBOURNE, Victoria, 28th June 2023 - Diag-Nose.io, a pioneering Australian healthtech start-up has emerged triumphant from four intense elimination rounds in the highly competitive …See details»
Investing In medtech so patients can breathe easier
Jan 30, 2025 “Backing Diag-Nose not only creates jobs right here in Victoria, it also drives economic growth and strengthens our reputation as a global leader in medtech.” Melbourne …See details»
Pulmonary Hypertension-Related Interstitial Lung Disease: An …
Jan 21, 2025 Therefore, suspicion for ILD needs to be high in an aging patient with non-specific pulmonary symptoms, and once the diagnosis is established, screening for pulmonary …See details»